Seattle Genetics Reports Second Quarter 2012 Financial Results
16:05 EDT 8 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Seattle
Genetics, Inc. (Nasdaq: SGEN) today reported financial results for
the second quarter ended June 30, 2012. The company also highlighted
progress with ADCETRIS (brentuximab vedotin) commercialization
activities, on...
Other Sources for this Article
Seattle Genetics
Investors:
Peggy Pinkston, 425-527-4160
ppinkston@seagen.com
or
Media:
Tricia
Larson, 425-527-4180
tlarson@seagen.com
More From BioPortfolio on "Seattle Genetics Reports Second Quarter 2012 Financial Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
